In silico methods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography/time-of-flight mass spectrometry urine drug screening

Rapid Communications in Mass Spectrometry

Volumn 23, Issue 4, 2009, Pages 506-514

  Pelander, Anna ^a   Tyrkkö, Elli ^a   Ojanperä, Ilkka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; BODY FLUIDS; DRUG PRODUCTS; FORECASTING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY;

'CURRENT; ANALYTICAL TOXICOLOGY; DRUG-SCREENING; FRAGMENTATION PREDICTION; IN-SILICO; LIQUID CHROMATOGRAPHY TIME-OF-FLIGHT MASS SPECTROMETRIES; MASS FRAGMENTATION; MASS SPECTRAL FRAGMENTATION; PHASE I; URINE SAMPLE;

METABOLITES;

EID: 60549107218     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3901     Document Type: Article

References (29)

1. Plumb RS, Jones MD, Rainville PD, Nicholson JK. J. Chromatogr. Sci. 2008; 46: 193.
2. Mortishire-Smith RJ, O'Connor D, Castro-Perez JM, Kirby J. Rapid Commun. Mass Spectrom. 2005; 19: 2659.
3. Ferrer I, Thurman EM. J. Chromatogr. A 2007; 1175: 24.
4. Ojanperä I, Pelander A, Laks S, Gergov M, Vuori E, Witt M. J. Anal. Toxicol. 2005; 29: 34.
5. Stroh JG, Petucci CJ, Brecker SJ, Huang N, Lau JM. J. Am. Soc. Mass Spectrom. 2007; 18: 1612.
6. Gergov M, Boucher B, Ojanperä I, Vuori E. Rapid Commun. Mass Spectrom. 2001; 15: 521.
7. Pelander A, Ojanperä I, Laks S, Rasanen I, Vuori E. Anal. Chem. 2003; 75: 5710.
8. Ojanperä S, Pelander A, Pelzing M, Krebs I, Vuori E, Ojanperä I. Rapid Commun. Mass Spectrom. 2006; 20: 1161.
9. Laks S, Pelander A, Vuori E, Ali-Tolppa E, Sippola E, Ojanperä I. Anal. Chem. 2004; 76: 7375.
10. Kolmonen M, Leinonen A, Pelander A, Ojanperä I. Anal. Chim. Acta 2007; 585: 94.
11. Pavlic M, Libiseller K, Oberacher H. Anal. Bioanal. Chem. 2006; 386: 69.
12. Nassar AE, Adams PE. Curr. Drug Metab. 2003; 4: 259.
13. Staack RF, Hopfgartner G. Anal. Bioanal. Chem. 2007; 388: 1365.
14. DeVane CL, Markowitz JS. In Metabolic Drug Interactions, Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum M (eds). LippincottWilliams & Wilkins: Philadelphia, 2000; 252.
15. Kulkarni SA, Zhu J, Blechinger S. Xenobiotica 2005; 35: 955.
16. DeVane LC, Nemeroff CB. Clin. Pharmacokinet. 2001; 40: 509.
17. Ereshefsky L. J. Clin. Psychiatry 1996; 57 (suppl 11): 12.
18. Nemeroff CB, Kinkead B, Goldstein, J. Clin. Psychiatry 2002; 63 (suppl 13): 5.
19. Mauri MC, Volonteri LS, Colasanti A, Fiorentini A, De Gaspari IF, Bareggi SR. Clin. Pharmacokinet. 2007; 46: 359.
20. Available: http://www1.astrazeneca-us.com/pi/Seroquel.pdf (accessed 18 August 2008).
21. Hakala KS, Kostiainen R, Ketola RA. Rapid Commun. Mass Spectrom. 2006; 20: 2081.
22. Nielen MW, van Engelen MC, Zuiderent R, Ramaker R. Anal. Chim. Acta 2007; 586: 122.
23. Ferrer I, Fernandez-Alba A, Zweigenbaum JA, Thurman EM. Rapid Commun. Mass Spectrom. 2006; 20: 3659.
24. García-Reyes JF, Hernando MD, Ferrer C, Molina-Díaz A, Fernández-Alba AR. Anal. Chem. 2007; 79: 7308.
25. Georgakopoulos CG, Vonaparti A, Stamou M, Kiousi P, Lyris E, Angelis YS, Tsoupras G, Wuest B, Nielen MW, Panderi I, Koupparis M. Rapid Commun. Mass Spectrom. 2007; 21: 2439.
26. Polettini A, Gottardo R, Pascali JP, Tagliaro F. Anal. Chem. 2008; 80: 3050.
27. Testa B, Balmat AL, Long A, Judson P. Chem. Biodivers. 2005; 2: 872.
28. Tiller PR, Yu S, Castro-Perez J, Fillgrove KL, Baillie TA. Rapid Commun. Mass Spectrom. 2008; 22: 1053.
29. Maurer HH. Anal. Bioanal. Chem. 2007; 388: 1315.